| Nome |
# |
|
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR), file de3e52b1-fbf1-762d-e053-3705fe0a30e0
|
185
|
|
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study, file de3e52af-f2d8-762d-e053-3705fe0a30e0
|
55
|
|
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy, file de3e52af-79ce-762d-e053-3705fe0a30e0
|
35
|
|
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer, file de3e52b0-4dc6-762d-e053-3705fe0a30e0
|
34
|
|
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy, file de3e52b0-42fd-762d-e053-3705fe0a30e0
|
29
|
|
Histological effects of givinostat in boys with Duchenne muscular dystrophy, file de3e52b0-4bec-762d-e053-3705fe0a30e0
|
24
|
|
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients, file de3e52b2-b826-762d-e053-3705fe0a30e0
|
21
|
|
Hippo signaling pathway is altered in Duchenne muscular dystrophy, file de3e52b1-ac65-762d-e053-3705fe0a30e0
|
20
|
|
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs, file de3e52b1-0a21-762d-e053-3705fe0a30e0
|
19
|
|
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions, file de3e52b1-144b-762d-e053-3705fe0a30e0
|
16
|
|
Dolori muscolari, deficit di forza e/o disturbi sensitivi, file de3e52b2-a933-762d-e053-3705fe0a30e0
|
9
|
|
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy, file de3e52b3-980e-762d-e053-3705fe0a30e0
|
9
|
|
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury., file de3e52b2-9868-762d-e053-3705fe0a30e0
|
7
|
|
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies, file de3e52b2-9ec3-762d-e053-3705fe0a30e0
|
7
|
|
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice, file de3e52af-7788-762d-e053-3705fe0a30e0
|
6
|
|
ANT1 is reduced in sporadic inclusion body myositis., file de3e52af-be7b-762d-e053-3705fe0a30e0
|
6
|
|
Dolori muscolari, deficit di forza e/o disturbi sensitivi, file de3e52b2-9c58-762d-e053-3705fe0a30e0
|
6
|
|
Stato dell'arte sulle terapie della Distrofia muscolare di Duchenne., file de3e52b0-6078-762d-e053-3705fe0a30e0
|
5
|
|
Dolori muscolari, deficit di forza e/o disturbi sensitivi, file de3e52b2-bd00-762d-e053-3705fe0a30e0
|
5
|
|
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle, file de3e52b2-a1e3-762d-e053-3705fe0a30e0
|
4
|
|
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance, file de3e52b3-bdd6-762d-e053-3705fe0a30e0
|
4
|
|
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone, file de3e52ae-bf76-762d-e053-3705fe0a30e0
|
3
|
|
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study, file de3e52b0-4b49-762d-e053-3705fe0a30e0
|
3
|
|
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report, file de3e52b0-6aa9-762d-e053-3705fe0a30e0
|
3
|
|
The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys, file de3e52b0-c901-762d-e053-3705fe0a30e0
|
3
|
|
Longitudinal evaluation of SMN levels as biomarker for spinal muscular atrophy: Results of a phase IIb double-blind study of salbutamol, file de3e52b2-9654-762d-e053-3705fe0a30e0
|
3
|
|
Dolori muscolari, deficit di forza e/o disturbi sensitivi, file de3e52b2-9c56-762d-e053-3705fe0a30e0
|
3
|
|
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life, file de3e52b2-b824-762d-e053-3705fe0a30e0
|
3
|
|
Emergenze respiratorie nelle malattie neurologiche, file de3e52b2-beb8-762d-e053-3705fe0a30e0
|
3
|
|
The role of metacognitive beliefs on anxiety and depression among Amyotrophic Lateral Sclerosis caregivers, file de3e52b3-1c1f-762d-e053-3705fe0a30e0
|
3
|
|
Muscle Pain, Weakness and/or Sensory Disorder, file de3e52b3-8a6d-762d-e053-3705fe0a30e0
|
3
|
|
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates, file de3e52b5-7069-762d-e053-3705fe0a30e0
|
3
|
|
The Genetic Landscape of Dystrophin Mutations in Italy: A Nationwide Study, file de3e52b2-28dd-762d-e053-3705fe0a30e0
|
2
|
|
null, file de3e52b2-9f2e-762d-e053-3705fe0a30e0
|
2
|
|
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study, file de3e52b2-a35d-762d-e053-3705fe0a30e0
|
2
|
|
Nusinersen versus sham control in later-onset spinal muscular atrophy, file de3e52b2-a95d-762d-e053-3705fe0a30e0
|
2
|
|
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center, file de3e52b2-b5b4-762d-e053-3705fe0a30e0
|
2
|
|
Emergenze respiratorie nelle malattie neurologiche, file de3e52b2-bee1-762d-e053-3705fe0a30e0
|
2
|
|
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis, file de3e52b3-129c-762d-e053-3705fe0a30e0
|
2
|
|
Molecular analysis of SMARD1 patient-derived cells demonstrates that nonsense-mediated mRNA decay is impaired, file 9d67e041-64e1-4e47-936f-5ad65ab6fe3d
|
1
|
|
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy, file de3e52ae-c903-762d-e053-3705fe0a30e0
|
1
|
|
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience., file de3e52ae-ceb9-762d-e053-3705fe0a30e0
|
1
|
|
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy., file de3e52ae-f413-762d-e053-3705fe0a30e0
|
1
|
|
Burden, professional support, and social network in families of children and young adults with muscular dystrophies, file de3e52af-79a2-762d-e053-3705fe0a30e0
|
1
|
|
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test, file de3e52af-79ab-762d-e053-3705fe0a30e0
|
1
|
|
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study, file de3e52af-7c34-762d-e053-3705fe0a30e0
|
1
|
|
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials, file de3e52b0-4bb4-762d-e053-3705fe0a30e0
|
1
|
|
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy, file de3e52b0-4dc9-762d-e053-3705fe0a30e0
|
1
|
|
Registries versus tertiary care centers: How do we measure standards of care in Duchenne muscular dystrophy?, file de3e52b0-5006-762d-e053-3705fe0a30e0
|
1
|
|
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements, file de3e52b3-1e00-762d-e053-3705fe0a30e0
|
1
|
|
Which are the factors influencing NIV adaptation and tolerance in ALS patients?, file de3e52b3-33ff-762d-e053-3705fe0a30e0
|
1
|
|
Clinical management of Duchenne muscular dystrophy: the state of the art, file de3e52b3-37e9-762d-e053-3705fe0a30e0
|
1
|
|
Longitudinal natural history in young boys with Duchenne muscular dystrophy, file de3e52b3-5089-762d-e053-3705fe0a30e0
|
1
|
|
null, file de3e52b3-6b36-762d-e053-3705fe0a30e0
|
1
|
| Totale |
568 |